Drug
Carvedilol phosphate hydrate clinical trials
Also written carvedilol phosphate.
A product of Carvedilol; its studies count on that page too.
How studies write it
Studies that test it under each name
Brand
Other names
Studies by the year they started
11 studies that test it; most in 2007 (6)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 6 |
| 2008 | 3 |
| 2010 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 5
GlaxoSmithKline (5) · CTI-1, LLC (1) · State University of New York at Buffalo (1) · University of South Florida (1) · University of Minnesota (1) · University of Florida (1) · University at Buffalo (1)
Often tested with
Tested in the same studies.
Carvedilol Phosphate Extended-Release Capsule (9) · Lisinopril (5) · Valsartan (1) · Atenolol (1)
Studies
Open first, then newest update. How each study uses carvedilol phosphate hydrate is read from its arms, and is right about nine times in ten.
Testing it · 11
- Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.TerminatedPhase 4University at BuffaloNCT00430040Written as Carvedilol Controlled Release (CR)
- A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart FailureCompletedPhase 3CTI-1, LLCNCT00323037Written as carvedilol controlled release
- Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to LisinoprilCompletedPhase 3State University of New York at BuffaloNCT00657241Written as Carvedilol CR
- Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving TrastuzumabCompletedPhase 2University of South FloridaNCT01009918Written as Coreg CR®
- Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural DiseaseCompletedPhase 1/2University of MinnesotaNCT00553969Written as carvedilol phosphate
- Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood PressureCompletedPhase 4University of FloridaNCT00669279Written as Carvedilol CR
- A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart FailureCompletedPhase 1GlaxoSmithKlineNCT00742508Written as SK&F-105517-D 10 mg capsule
- Study to Demonstrate the Bioequivalence of the Fixed Dose Combination of COREG CR™ and Lisinopril to Its ComponentsCompletedPhase 1GlaxoSmithKlineNCT00556920Written as COREG CR
- Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.CompletedPhase 1GlaxoSmithKlineNCT00549510Written as COREG CR and lisinopril (FDC)
- A Study Investigating the Bioequivalence of the Fixed Dose Combination of COREG CR to COREG CR and ZESTRIL.CompletedPhase 1GlaxoSmithKlineNCT00552708Written as COREG CR
- Study to Examine the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination of COREG CR and Lisinopril.CompletedPhase 1GlaxoSmithKlineNCT00557128Written as COREG CR and lisinopril (FDC)
As the comparator · 1 — what is tested is compared with carvedilol phosphate hydrate
Codes
What other systems call carvedilol phosphate hydrate · ClinicalTrials.gg INT016478
- UNII (FDA) EQT531S367CARVEDILOL PHOSPHATEConfirmed FDA, Wikidata
- RxNorm 668310Confirmed FDA, Wikidata
- Wikidata Q27277316carvedilol phosphate hydrateConfirmed FDA, Wikidata
- NCI Thesaurus C65292Carvedilol PhosphateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | EQT531S367 | CARVEDILOL PHOSPHATE | Confirmed FDA, Wikidata |
| RxNorm | 668310 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27277316 | carvedilol phosphate hydrate | Confirmed FDA, Wikidata |
| NCI Thesaurus | C65292 | Carvedilol Phosphate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.